Note 12 - Employee Savings Plan

12 Months Ended

Dec. 31, 2018

Notes to Financial Statements

Compensation and Employee Benefit Plans [Text Block]

1

2

. Employee Savings Plan

The terms of the amended and restated Progenics Pharmaceuticals

401

(k) Plan (the

“401

(k) Plan”), among other things, allow eligible employees to participate in the Amended Plan by electing to contribute to the

401

(k) Plan a percentage of their compensation to be set aside to pay their future retirement benefits. We matched

50%

of employee contributions equal to

1%

-

10%

of compensation during the

three

years ended

December 31, 2018,

made by eligible employees to the

401

(k) Plan (the “Matching Contribution”). In addition, we

may

also make a discretionary contribution each year on behalf of all participants who are non-highly compensated employees. We made Matching Contributions of approximately

$381

thousand,

$302

thousand, and

$281

thousand to the

401

(k) Plan for the years ended

December 31, 2018,

2017,

and

2016,

respectively.

No

discretionary contributions were made during those years.